
|Videos|June 19, 2021
Assessing IOL options for cataract patients
Author(s)OT Staff Reports, Alex Delaney-Gesing
In recognition of Cataract Awareness Month, Fasika Woreta, MD, MPH, discusses IOL options for cataract patients.
Advertisement
Fasika Woreta, MD, MPH, of the Wilmer Eye Institute, Johns Hopkins University School of Medicine, discusses the determining factors and indicators to consider when treating cataract patients with IOLs.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025 Takeaways: The new era of glaucoma treatment and surgical precision
2
AAO 2025 Takeaways: The next frontier in retinal therapeutics arrives
3
AGC Biologics to manufacture AAVantgarde’s dual-vector gene therapies, AVB-039 and AAVB-081
4
Managing Unique Dry Eye Disease Subtypes in Patients
5


















































.png)


